Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between CYP3A5 polymorphisms and blood pressure in kidney transplant recipients receiving calcineurin inhibitors.

Clinical and experimental hypertension (New York, N.Y. : 1993) - 1 Jan 2011

Ferraresso Mariano, Turolo Stefano, Ghio Luciana, Tirelli Amedea S, Belingheri Mirco, Villa Roberta, Groppali Elena, Edefonti Alberto

Abstract excerpt

Abstract Renal cytochrome P450 3A5 (CYP3A5) has been associated with blood pressure (BP) control in humans. We investigated whether CYP3A5 polymorphisms are associated with post- transplant hypertension in a selected population of kidney recipients receiving calcineurin inhibitors. Ninety-two kid...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Pressure
Share to Calcineurin Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclosporine

Share to Cytochrome P-450 CYP3A

Share to Hypertension

Share to Kidney Transplantation

Share to Severity of Illness Index

Share to Tacrolimus

Source

Identifiers

PMID: 21851254
DOI: 10.3109/10641963.2011.561896

Genes

DBP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21851254-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between CYP3A5 polymorphisms and blood pressure in kidney transplant recipients receiving calcineurin inhibitors.PMID 21851254Read ↗

Effect of CYP3A51/3 polymorphism on blood pressure in renal transplant recipients.Semantic proximity Read ↗

The effect of variable CYP3A5 expression on cyclosporine dosing, blood pressure and long-term graft survival in renal transplant patients.Semantic proximity Read ↗

CYP3A5 polymorphism, amlodipine and hypertension.Semantic proximity Read ↗

Influence of the CYP3A5 genotype on tacrolimus pharmacokinetics and pharmacodynamics in young kidney transplant recipients.Semantic proximity Read ↗

Association between renal function and CYP3A5 genotype in heart transplant recipients treated with calcineurin inhibitors.Semantic proximity Read ↗

The Prognostic Role of CYP Enzyme in Kidney Transplantation: A Single Centre Experience.Semantic proximity Read ↗

Clinical impact of the CYP3A5 6986A>G allelic variant on kidney transplantation outcomes.Semantic proximity Read ↗

CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults.Semantic proximity Read ↗

Tacrolimus-induced nephrotoxicity and genetic variability: a review.Semantic proximity Read ↗

CYP3A4*1G and CYP3A5*3 genetic polymorphisms alter the antihypertensive efficacy of amlodipine in patients with hypertension following renal transplantation .Semantic proximity Read ↗

CYP3A5 genotype is associated with elevated blood pressure.Semantic proximity Read ↗

Role of pharmacogenomics in dialysis and transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.